Toronto, Ontario--(Newsfile Corp. - November 30, 2022) - Hill Street Beverage Company Inc. (TSXV: HILL) (OTC Pink: HSEEF) ("Hill Street" or the "Company"), a progressive bioscience implementation company that utilizes new technologies to provide innovative cannabis solutions and non-alcoholic beverage products, is pleased to announce the following updates from the recently completed Q1 of FY 2023. All dollar figures are quoted in Canadian dollars.
New Product Launches Hit the Market for DehydraTECH™ Licensees
The Company continued to expand its geographic footprint and its portfolio of DehydraTECH™-powered consumer product form factors during the three-month period ended September 30, 2022.
1906 Drops expanded to Michigan, Pennsylvania, and Ohio, and several of the newer DehydraTECH™ licensees, which Hill Street's commercialization partner Dehydr8 has been working with to develop their commercial manufacturing operations, executed their initial product launches in market. These include:
Lume Cannabis Co. launched their first DehydraTECH™-powered products under their brand in Michigan dispensaries.
Folium Farms prepared for the launch of their Karma brand utilizing DehydraTECH™ in Oregon, which subsequently occurred in early October 2022.
DehydraTECH™ licensing revenues grew by 34% in Q1 versus the same quarter one year ago and the Company expects the financial impact of these new licensee launches to build over the coming quarters.
The Transformed Vin(Zero) Business Model Continues to Drive First Half Strength
As previously announced, the Company's new streamlined Vin(Zero) alcohol-free beverage business model creates a new and different cadence to the business. We now focus on executing larger orders on a semi-annual basis to greatly increase operational efficiency, versus fragmented monthly or quarterly ordering. Consequently, this business must now be looked at across longer time frames to truly understand its momentum.
Record revenues reported in Q4 FY2022 of over $1MM (vs. average net revenue trends of approximately $475K per quarter) continued to support the Vin(Zero) go-to-market distribution system and retail sales during Q1 FY2023. The result of this new pattern and the large Q4, is significantly lower revenues for this quarter.
However, as of today, Hill Street has already received and sold the Vin(Zero) inventory that it ordered during this past summer and expects Vin(Zero) revenues of over $900,000 in Q2 FY 2023. With these Q2 expected revenues, we anticipate seeing double-digit revenue growth for the full six-month period ended December 31, 2022 compared to the same six-month period in calendar 2021.
*Note: The FY2023 Q2 Vin(Zero) revenue expectations are subject to revision, and anticipated to be finalized and included with the Company's FY2023 Q2 financials release by March 1, 2023. The Company's actual FY2023 Q2 Vin(Zero) business financial results could differ materially from these selected preliminary results. Any preliminary unaudited financial projections provided herein have not been prepared in accordance with IFRS.
Release of Q1 FY2023 Financial Statements and MD&A
For the three-month period ended September 30, 2022, the Company has released its Financial Statements, and a comprehensive Company update by way of its Management Discussion and Analysis, which can now be found on the Company's profile at www.sedar.com.
Craig Binkley, CEO, comments: "Our Q1 results were in line with our expectations, as previously communicated to our shareholders. We are also very pleased that our expected December 31, 2022 results for the Vin(Zero) business validate that the fundamental adjustments we made earlier this year were well considered and on target. By refocusing our efforts towards our two strong-margined and streamlined business segments - Vin(Zero) beverage sales and DehydraTECH™ licensing - we are well positioned to show strong growth as we head into calendar 2023."
About Hill Street Beverage Company Inc. (TSXV: HILL)
Hill Street is a progressive bioscience implementation company that utilizes new technologies to provide innovative cannabis solutions and non-alcoholic beverage products globally. We are pioneering the space where craft consumer products meet bioscience by leveraging our deep CPG expertise. We are currently developing the platform for our North American distribution around our rights to use Lexaria Bioscience Corp.'s ground-breaking DehydraTECH™ patent portfolio for product development, licensing and B2B sales of cannabis ingredients.
For more information on our business activities or to check out Hill Street's award-winning alcohol-free line-up and order product to be delivered straight to your home go to www.hillstreetbeverages.com
For more information:
Craig Binkley, Chief Executive Officer
Statements in this press release may contain forward-looking information. Any statements in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "would", "anticipate", "expects", and similar expressions. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances, such as future availability of capital on favourable terms, may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement. The forward-looking statements contained in this press release are made as of the date of this press release. The Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as required by securities law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Not for dissemination in the United States.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/146184